BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23384902)

  • 1. [Exploration of early assessment of renal impairment in multiple myeloma].
    Zhong Y; Yuan ZG; Fu WJ; Zhou F; Zhang CY; Zhang WH; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):819-22. PubMed ID: 23384902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
    Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
    Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of low molecular weight urinary protein for assessment of early renal damage in patients with multiple myeloma].
    Liu SJ; Zhai YP; Yu YP; Liu HN; Li F; Song P; Zhou XG; An ZM; Shao JJ; Yang XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):410-4. PubMed ID: 23628043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil gelatinase-associated lipocalin as a biomarker of renal impairment in patients with multiple myeloma.
    Chae H; Ryu H; Cha K; Kim M; Kim Y; Min CK
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):35-40. PubMed ID: 25204517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
    Lebkowska U; Malyszko J; Lebkowska A; Koc-Zorawska E; Lebkowski W; Malyszko JS; Kowalewski R; Gacko M
    Transplant Proc; 2009; 41(1):154-7. PubMed ID: 19249501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
    Arun O; Celik G; Oc B; Unlu A; Celik JB; Oc M; Duman A
    Kidney Blood Press Res; 2015; 40(2):141-52. PubMed ID: 25832128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology.
    Schaub S; Mayr M; Hönger G; Bestland J; Steiger J; Regeniter A; Mihatsch MJ; Wilkins JA; Rush D; Nickerson P
    Transplantation; 2007 Jul; 84(1):104-12. PubMed ID: 17627245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cystatin C and NGAL as early biomarkers for assessment of renal ischemia-reperfusion injury: a serum marker to replace creatinine?
    Woodson BW; Wang L; Mandava S; Lee BR
    J Endourol; 2013 Dec; 27(12):1510-5. PubMed ID: 24266750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L; Pu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated urinary levels of cystatin C and neutrophil gelatinase-associated lipocalin in Henoch-Schönlein purpura patients with renal involvement.
    Chen T; Lu YH; Wang WJ; Bian CY; Cheng XY; Su Y; Zhou PM
    PLoS One; 2014; 9(6):e101026. PubMed ID: 24963810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary NGAL for the diagnosis of the renal injury from multiple myeloma.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M
    Cancer Biomark; 2017; 18(1):41-46. PubMed ID: 27814274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
    Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
    Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
    Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
    Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein.
    Donadio C
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1407-23. PubMed ID: 20844024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.